CXMT's July 27 STAR Market debut is less about one Chinese IPO than about who pays for the next memory cycle. You should watch the HBM gap, not the first-day pop.
The numbers are hard to ignore. ChangXin Memory Technologies has priced its Shanghai IPO at 8.66 yuan a share and is expected to raise 57.9 billion yuan, about $8.55 billion, before any greenshoe option. Reuters reported that the Hefei-based chipmaker is set to debut on Monday, July 27, making it Asia's largest IPO so far this year and China's biggest A-share semiconductor listing. That is not a quiet market event.
The timing is ugly. As CNBC reported, the offering has stirred worries that investors will pull cash from other Chinese chip and technology names to make room for CXMT. Tim Sun, a senior researcher at HashKey Group, told CNBC that the listing is intensifying concern about a liquidity squeeze, partly because the market expects CXMT's valuation to push above 1 trillion yuan, about $139 billion, after trading begins. Some offshore speculation has pointed far higher. Don't confuse that with proof of value. Retail heat often tells you more about crowd behavior than industrial strength.
But the excitement isn't coming from nowhere. CXMT is China's largest DRAM producer and, according to its prospectus cited by Reuters, held about 7.7% of the global DRAM market in 2025. Its first-quarter 2026 revenue reached 50.8 billion yuan, up 719.13% from a year earlier, while net profit rose to 33.012 billion yuan, according to figures carried by the Shanghai Stock Exchange from Global Times and company filings. For a company that was still a small share player only a few years ago, that is a serious shift.
You don't need to romanticize it. CXMT has benefited from a brutal memory upcycle as AI servers, cloud expansion, smartphones and PCs all compete for supply. DRAM prices have moved sharply, and CXMT entered the IPO window with numbers that look almost unreal because the cycle turned in its favor. A strong company can still be riding a strong cycle. Investors forget that distinction at their own cost.
The HBM gap is still the story
The IPO pitch gets more complicated when you move from commodity DRAM to high-bandwidth memory. HBM is the memory stacked beside AI accelerators in Nvidia-class systems, and it is where SK Hynix, Samsung and Micron still have the real technical lead. SemiAnalysis recently estimated that CXMT's HBM wafer capacity could rise sharply through 2027 and 2028, but it also said the company's HBM technology is still maturing - and there remains a strong economic reason to keep most capacity in commodity DRAM for now.
That matters for anyone tempted to treat CXMT as an instant HBM rival. The company may have roughly 265,000 wafer starts per month today across its broader DRAM base, but the HBM allocation is tiny by comparison. SemiAnalysis estimates CXMT could reach 55,000 HBM wafer starts per month in 2027 and 100,000 in 2028, lifting its share of global HBM wafer supply from about 1% in 2025 to 12% by 2028. That is a meaningful roadmap. It is not the same thing as shipping at SK Hynix's quality, volume and customer qualification level.
Here's the thing: CXMT doesn't have to beat SK Hynix next year to change the market. If it adds enough conventional DRAM supply, it can pressure the part of the market where pricing is most cyclical. SemiAnalysis expects CXMT's total DRAM capacity share to rise toward roughly 17% by 2028, up from 11% in 2025. The Financial Times recently noted that memory investors are already debating whether AI demand can absorb the industry's expansion, with CXMT's capacity growth sitting as one of the biggest swing factors.
Micron knows this is not background noise. The South China Morning Post reported in June that Micron chief business officer Sumit Sadana acknowledged CXMT and YMTC had grown in capability and market share, while also saying most of their output was still sold inside China. That is the right framing. CXMT is not yet displacing the big three in the most advanced AI memory sockets. It is, however, big enough to change the supply picture in the products just below that premium tier.
Who benefits if CXMT delivers
For Chinese AI buyers, a better-capitalized CXMT is useful even before it becomes an HBM leader. Alibaba, Baidu, ByteDance and domestic cloud providers need memory supply that is less exposed to US export controls and Korean allocation decisions. If CXMT can supply more advanced DRAM at scale, those companies gain bargaining power. If it can eventually deliver credible HBM3-class products, the balance changes further.
For Western chip stocks, the signal is mixed. Near term, the IPO can drain liquidity from Chinese technology shares and keep investors jumpy across the sector. Medium term, CXMT is a state-backed fourth player with fresh capital and a rapidly expanding capacity base - operating in a home market that wants exactly what it sells. SK Hynix and Micron don't need to panic. They would be foolish to look away.
The first-day valuation will get the headlines on Monday. Watch the capacity disclosures after that. A hot IPO can fade in a week, but 500,000 wafer starts per month by 2028 would live in memory pricing for years.
Also read: Amazon orders sellers to label AI-generated people in product images after New York law • Oracle locks the entire US military into a 10-year, $7 billion on-premises software deal • China's memory chipmakers are racing to break the Korean stranglehold on AI infrastructure
